Skip to main content

Table 3 The frequency and intensity of HPV16 E7 single peptide-specific T cell response

From: HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer

HPV16 E7 peptide Squamous cell carcinoma of cervix (n = 76)
Frequency (%) Mean magnitude (SFC/106)
E7 Peptide-1 MHGDTPTLHEYMLDLQPE1-18 15.79 46.92
E7 Peptide-2 HEYMLDLQPETTDLYCYE9-26 11.84 39.78
E7 Peptide-3 PETTDLYCYEQLNDSSEE17-34 10.53 45.37
E7 Peptide-4 YEQLNDSSEEEDEIDGPA25-42 15.79 52.00
E7 Peptide-5 EEEDEIDGPAGQAEPDRA33-50 11.84 44.00
E7 Peptide-6 PAGQAEPDRAHYNIVTFC41-58 9.21 43.43
E7 Peptide-7 RAHYNIVTFCCKCDSTLR49-66 11.84 40.89
E7 Peptide-8 FCCKCDSTLRLCVQSTHV57-74 11.84 46.33
E7 Peptide-9 LRLCVQSTHVDIRTLEDL65-82 13.16 53.10
E7 Peptide-10 HVDIRTLEDLLMGTLGIV73-90 15.79 55.33
E7 Peptide-11 DLLMGTLGIVCPICSQKP81-98 15.79 46.83
  1. HPV, human papillomavirus